You just read:

FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity

News provided by

Allergan plc

Mar 07, 2019, 08:00 ET